ALFA Finder
18:32 IST
BSE
Other Announcement
Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Ltd
- Share price
- ₹26.00
- Market cap
- ₹13.19 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 21.1×Sector 43.8×
- Promoter holding
- 27.97%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Date 5Board Meeting Outcome 4Promoter Buying 3Financial Results 3Annual General Meeting 3Other Announcement 2Capacity Expansion 1Annual Report 1Adverse Business Impact 1
Time
2 announcements with these filters
18:44 IST
BSE
Other Announcement
Beryl Drugs Other Announcement
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.